Several studies have also outlined a strong regulatory role of HMGB1 in driving the onset and progression of secondary renal damage, viz., glomerulonephritis, diabetic nephropathy (DN), and lupus nephritis (LN). Here, HMGB1 is linked to lobular neoplasia.